A detailed history of Aurora Investment Counsel transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Aurora Investment Counsel holds 63,571 shares of HRMY stock, worth $2.16 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
63,571
Previous 62,878 1.1%
Holding current value
$2.16 Million
Previous $1.99 Million 11.78%
% of portfolio
1.02%
Previous 1.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$26.76 - $38.05 $18,544 - $26,368
693 Added 1.1%
63,571 $1.75 Million
Q2 2025

Jul 30, 2025

BUY
$27.94 - $35.91 $33,835 - $43,487
1,211 Added 1.96%
62,878 $1.99 Million
Q1 2025

May 01, 2025

BUY
$32.18 - $40.46 $12,035 - $15,132
374 Added 0.61%
61,667 $2.05 Million
Q4 2024

Feb 10, 2025

BUY
$31.86 - $41.49 $1.95 Million - $2.54 Million
61,293 New
61,293 $2.11 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Aurora Investment Counsel Portfolio

Follow Aurora Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Aurora Investment Counsel with notifications on news.